US STOCK
BSX Stock Analysis
US stocks · market data · technical indicators
Boston Scientific Corp.
BSXUS stocksQuote delayed 15 min
10/27 上午02:49 updated
$45.38
-0.31-0.68%
Open
$45.31
High
$46.07
Low
$45.13
Volume
623.30萬
BSX price history
+2.98%Open
44.11
Latest
45.43
High
46.01
Low
41.58
Average
43.78
Advertisement
Financial snapshot
BSX - Boston Scientific Corporation
EPS
2.47USD
Forward EPS
3.38USD
P/E
18.39x
Forward P/E
13.45x
P/B
2.64x
ROE
15.34%
ROA
6.19%
Operating margin
22.90%
Profit margin
17.50%
Revenue growth
7.50%
Earnings growth
15.10%
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | — | $5.20B | $5.29B | $5.07B | $5.06B | $4.66B |
| Gross profit | — | $3.61B | $3.68B | $3.54B | $3.42B | $3.21B |
| Operating income | — | $1.07B | $1.04B | $1.05B | $943.00M | $937.00M |
| Net income | — | $1.34B | $672.00M | $755.00M | $797.00M | $674.00M |
| Basic EPS | 0.62 | 0.90 | 0.45 | 0.51 | 0.54 | — |
| Diluted EPS | 0.61 | 0.90 | 0.45 | 0.51 | 0.53 | — |
Estimates vs actuals
Next earnings
2026-10-28
EPS estimate
0.72
Revenue estimate
$5.05B
Last surprise
+3.86%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-28 | 0.72 | Not reported | — |
| 2026-07-29 | 0.83 | 0.86 | +3.86% |
| 2026-04-22 | 0.79 | 0.80 | +1.62% |
| 2026-02-04 | 0.78 | 0.80 | +2.43% |
| 2025-10-22 | 0.71 | 0.75 | +5.09% |
| 2025-07-23 | 0.73 | 0.75 | +3.42% |
| 2025-04-23 | 0.67 | 0.75 | +11.52% |
| 2025-02-05 | 0.66 | 0.70 | +6.57% |
| 2024-10-23 | 0.59 | 0.63 | +7.05% |
| 2024-07-24 | 0.58 | 0.62 | +6.51% |
| 2024-04-24 | 0.51 | 0.56 | +9.14% |
| 2024-01-31 | 0.51 | 0.55 | +7.33% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $13.3B | 0.19% |
| BlackRock Inc. | 2024-06-30 | $9.7B | 0.22% |
| STATE STREET CORP | 2026-06-30 | $3B | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $826.2M | 0.60% |
| CITADEL ADVISORS LLC | 2026-06-30 | $212.9M | 0.02% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $102.9M | 0.14% |
| Bridgewater Associates, LP | 2026-06-30 | $18.9M | 0.08% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$57.82
Target range
$44.00 – $78.00
Implied upside
27.28%
Strong buy
6
Buy
18
Hold
6
Sell
0
Strong sell
0
Advertisement